Emerging Biomarkers in Hypertension
NCT02064218 · Status: UNKNOWN · Type: OBSERVATIONAL
Last updated 2014-02-17
Summary
First of all to evaluate the relationship between non-conventional biomarkers and essential hypertension; then to evaluate the effects of various anti-hypertensive drugs on blood pressure control and non-conventional biomarkers in naive hypertensive patients
Conditions
Interventions
- DRUG
-
Anti-hypertensive drugs
Sponsors & Collaborators
-
Fondazione IRCCS Policlinico San Matteo di Pavia
collaborator OTHER -
University of Pavia
lead OTHER
Principal Investigators
-
Giuseppe Derosa, MD, PhD · University of Pavia
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-11-30
- Primary Completion
- 2014-01-31
Countries
- Italy
Study Locations
More Related Trials
-
A Study for the Identification of Biomarker Signatures for Early Detection of Pulmonary Hypertension (PH)
NCT04193046 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Feasibility Study of the Intensive Systolic Blood Pressure Control
NCT02817503 ·Status: UNKNOWN ·Phase: PHASE4
-
The Standardized Management of Hypertension in Rural Shaanxi
NCT04371874 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
NCT06682000 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of A Hemodynamic-Guided Treatment Strategy to Improve Blood Pressure Control
NCT04715698 ·Status: COMPLETED ·Phase: NA
-
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
NCT01703780 ·Status: UNKNOWN
-
A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
NCT06671392 ·Status: COMPLETED ·Phase: PHASE3
-
New Biomarkers and Difficult-to-treat Hypertension
NCT03034265 ·Status: COMPLETED
-
Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
NCT03592667 ·Status: UNKNOWN ·Phase: PHASE4
-
Hypertension in High School Students
NCT06049641 ·Status: COMPLETED
-
Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives
NCT04531124 ·Status: NOT_YET_RECRUITING
-
Effect of Blood Pressure on Myocardial Work in Patients With Hypertension
NCT05062811 ·Status: UNKNOWN
-
Italian Digital Primary Cardiovascular Prevention Study
NCT05339841 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients
NCT00337038 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
NCT02563405 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Role of AT1-receptor Blockers in Insulin-induced Vasodilation.
NCT00742066 ·Status: UNKNOWN ·Phase: NA
-
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.
NCT06208072 ·Status: RECRUITING ·Phase: NA
-
Multi-center Study on New Cardiovascular Remodeling and Function Parameters in Hypertension
NCT05638503 ·Status: RECRUITING
-
MANP in African Americans With Hypertension
NCT04542681 ·Status: WITHDRAWN ·Phase: PHASE1
-
Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
NCT00681278 ·Status: COMPLETED
-
Correlates and Control of Blood Pressure Variability
NCT06012487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Antihypertensive Drug Selection Based on Hemodynamic Phenotypes
NCT07240909 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Analysis of Antihypertensive Treatment Efficacy
NCT00767247 ·Status: TERMINATED
-
Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy
NCT06858345 ·Status: RECRUITING
-
Prehypertension and Dietary Supplements - The PYRAMIDS Study
NCT01682291 ·Status: UNKNOWN ·Phase: PHASE4